ContraFect Reports Second Quarter 2022 Financial Results and Provides Corporate Update Posted on August 15, 2022 By News Desk Focused on advancement of lead programs, exebacase and CF-370, into new clinical studies Focused on advancement of lead programs, exebacase and CF-370, into new clinical studies Read more Globe Newswire
